Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Chemours stock
Learn how to easily invest in Chemours stock.
Chemours is a specialty chemicals business based in the US. Chemours shares (CC) are listed on the NYSE and all prices are listed in US Dollars. Chemours employs 6,600 staff and has a trailing 12-month revenue of around $6.8 billion.
How to buy Chemours stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Chemours stock price (NYSE: CC)Use our graph to track the performance of CC stocks over time.
Chemours shares at a glance
|Latest market close||$29.12|
|52-week range||$23.23 - $43.96|
|50-day moving average||$33.82|
|200-day moving average||$32.75|
|Wall St. target price||$39.10|
|Dividend yield||$1 (3.22%)|
|Earnings per share (TTM)||$3.35|
Buy Chemours stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Chemours stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Chemours price performance over time
Historical closes compared with the close of $29.12 from 2023-03-20
|1 week (2023-03-14)||-6.34%|
|1 month (2023-02-21)||-12.94%|
|3 months (2022-12-21)||-5.91%|
|6 months (2022-09-21)||3.48%|
|1 year (2022-03-17)||N/A|
|2 years (2021-03-19)||10.41%|
|3 years (2020-03-20)||247.95%|
|5 years (2018-03-21)||40.9138|
Is Chemours stock undervalued or overvalued?
Valuing Chemours stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chemours's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Chemours's P/E ratio
Chemours's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Chemours shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Chemours's PEG ratio
Chemours's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6685. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chemours's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Chemours's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a Chemours's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$6.8 billion|
|Operating margin TTM||11.67%|
|Gross profit TTM||$1.6 billion|
|Return on assets TTM||6.53%|
|Return on equity TTM||52.81%|
|Market capitalisation||$4.3 billion|
TTM: trailing 12 months
Chemours share dividends
Dividend payout ratio: 25.36% of net profits
Recently Chemours has paid out, on average, around 25.36% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.22% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Chemours shareholders could enjoy a 3.22% return on their shares, in the form of dividend payments. In Chemours's case, that would currently equate to about $1 per share.
While Chemours's payout ratio might seem fairly standard, it's worth remembering that Chemours may be investing much of the rest of its net profits in future growth.
Chemours's most recent dividend payout was on 14 March 2023. The latest dividend was paid out to all shareholders who bought their shares by 22 February 2023 (the "ex-dividend date").
Chemours share price volatility
Over the last 12 months, Chemours's shares have ranged in value from as little as $23.2252 up to $43.9633. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chemours's is 1.8843. This would suggest that Chemours's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Chemours in the news
How Better Chemistry Catalyzes Decarbonization
Chemours Titanium Technologies & Chemical Solutions Business President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader
12 Best US Chemical Stocks To Buy Now
Frequently asked questionsWhat percentage of Chemours is owned by insiders or institutions?
Currently 0.714% of Chemours shares are held by insiders and 75.287% by institutions. How many people work for Chemours?
Latest data suggests 6,600 work at Chemours. When does the fiscal year end for Chemours?
Chemours's fiscal year ends in December. Where is Chemours based?
Chemours's address is: 1007 Market Street, Wilmington, DE, United States, 19899 What is Chemours's ISIN number?
Chemours's international securities identification number is: US1638511089 What is Chemours's CUSIP number?
Chemours's Committee on Uniform Securities Identification Procedures number is: 163851108
More guides on Finder
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Ask an Expert